Proactiveinvestors recommends

Additional Information

Market:	ASX
Sector:	Gold Mining
EPIC:	RMS
Latest Price:	1.13 (2.27% )
52-week High:	1.70
52-week Low:	0.92
Market Cap:	328.35M

1 year chart

1 day chart

Ramelius Resources

Ramelius Resources (ASX: RMS) was listed on the ASX in March 2003 to explore gold and nickel projects Goldfields of Western Australia.

The Company discovered the Wattle Dam Gold Mine in 2005 and began mining the deposit in March 2006. In 2007 the Company purchased the Burbanks milling facility for $2.8 million to treat the high grade Wattle Dam ore.

Ramelius Resources announces record production at Wattle Dam

Wednesday, January 06, 2010

Shares in Australian-listed miner Ramelius Resources (ASX: RMS) rose 2.5c after announcing record production at the Wattle Dam Gold Mine, located in the Goldfields of Western Australia.

The Perth-based company recorded production of 19,970 oz gold @ 40.88g/t, while gold sales in the month of December 2009 totalled $19.9 million, which has exceeded total gold sales by Ramelius in any previous full financial year.

During the afternoon trade following the announcement, Ramelius shares jumped 2.5c, or 4.6%, to 57c.

Final results for milling of the initial Wattle Dam development ore parcel were 15,632 dry tonnes milled at a head grade 40.88g/t producing 19,970 oz of gold.

Ramelius chief executive Ian Gordon said the results from the development ore parcel were excellent, with actual grades more than three times that estimated from final underground sampling of 12.62 g/t Au.

"This grade overcall is similar to what was encountered during previous mining campaigns at Wattle Dam and gives the Company a high degree of confidence that the underground ore grades will continue to outperform base case estimates," Mr Gordon said.

In line with the mine plan, Ramelius has commenced stoping high grade underground ore at Wattle Dam and expects to commence milling this material from late January 2010.

Meanwhile, Ramelius currently has an interest in Dioro Exploration NL of 36.95%. Its offer for Dioro, which was recently increased to 2.1 Ramelius shares per Dioro share, will remain open until the 8th of February 2010.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.